相关实验视频
Updated: May 10, 2026
06:26
Pre-clinical Model of Cardiac Donation after Circulatory Death
Published on: August 2, 2019
7.9K
儿科患者心脏的HTK解决方案:元分析
Lorhayne Kerley Capuchinho Scalioni Galvao1, Ana Clara Felix de Farias Santos2, Nicole Pimenta Dos Santos3
1Federal University of Minas Gerais Medicine School, Belo Horizonte, Brazil.
The Thoracic and cardiovascular surgeon
|November 5, 2024
概括
希斯蒂丁-三-甲酸 (HTK) 溶液在儿科心血管外科手术中显示出与其他心脏方法相比的临床疗效. 它可能为患有流体过载风险的患者提供好处.
科学领域:
- 心血管外科心血管外科
- 儿科心脏麻醉 儿科心脏麻醉
- 心脏的解决方案 心脏的解决方案
背景情况:
- 心脏对于心血管手术至关重要,使可逆性心脏骤停成为可能.
- 希斯蒂丁-酸-酸 (HTK) 溶液是一种广泛使用的药理方法.
- 关于HTK有效性的有限的元分析存在,特别是在儿科患者群体中.
研究的目的:
- 对儿科患者进行元分析,比较HTK溶液与其他心解决方案的疗效.
- 通过使用不同的心策略,评估儿科心血管外科手术的关键临床结果.
主要方法:
- 在PubMed,Embase和Cochrane数据库中进行系统的文献搜索,截至2024年4月.
- 对11项涉及1349名儿科患者的研究进行了元分析.
- 使用几率比率 (OR) 分析二分类变量,使用平均差异 (MD) 分析连续变量,使用 95% 置信区间 (CI).
主要成果:
- 在HTK与其他溶液之间,死亡率,住院时间,机械通风持续时间,心律失常或延迟胸关闭方面没有发现显著差异.
- 在HTK组观察到输血体积的统计显著减少 (MD -452.39 mL;95% CI -890.24, -14.53;p=0.04).
结论:
- 在小儿心血管外科手术中,HTK溶液的临床疗效与替代性心肌解决方案相似.
- 由于输血需求减少,HTK可能会带来优势,特别是对于容易患上高血的儿科患者.
相关概念视频
01:21Cardiopulmonary Resuscitation I: Adult
Cardiopulmonary resuscitation, or CPR, is a life-saving emergency procedure performed when a person's heart has stopped beating or they are no longer breathing. The foundation of CPR is Basic Life Support (BLS), which focuses on the early recognition of cardiac arrest, the immediate start of high-quality chest compressions, and the timely use of an automated external defibrillator (AED).Assessing Responsiveness and Checking the Carotid PulseWhen approaching an unresponsive person, first ensure...
01:25Cardiopulmonary Resuscitation IV: Pharmacological Management
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
01:30Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
01:29Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...